Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 12.71%35.34K | 135.97%15.08K | -248.01%-67.08K | 99.79%-414 | 52.25%-35.17K | 122.95%31.35K | -1,330.65%-41.92K | 133.71%45.32K | 58.33%-201.74K | -169.48%-73.66K |
| Net income from continuing operations | 79.09%-6.74K | 55.50%-27.59K | 92.04%-3.22K | 45.71%-146.06K | 62.07%-11.39K | -53.27%-32.23K | 39.49%-62K | 65.05%-40.46K | 49.92%-269.04K | 74.49%-30.02K |
| Operating gains losses | 0.00%4.45K | 0.00%4.45K | 0.00%4.3K | ---- | ---- | 0.00%4.45K | -49.17%4.45K | 0.00%4.3K | ---- | ---- |
| Depreciation and amortization | -22.47%452 | -22.47%452 | -90.09%451 | -87.53%6.3K | -95.03%583 | -95.49%583 | -88.64%583 | -64.80%4.55K | 16.09%50.51K | -0.63%11.73K |
| Remuneration paid in stock | --0 | --0 | ---- | --19K | --0 | --0 | 0.00%19K | ---- | --0 | --0 |
| Other non cashItems | ---- | ---- | -46.89%1.68K | -50.76%1.55K | 5,390.91%582 | 0.27%-1.09K | -153.06%-1.09K | -49.69%3.16K | -83.57%3.15K | -100.06%-11 |
| Change In working capital | -37.67%37.17K | 1,420.31%37.76K | -195.29%-70.3K | 2,624.26%101.15K | 50.85%-29.4K | 217.08%59.64K | -104.03%-2.86K | 274.72%73.77K | 91.89%-4.01K | -207.35%-59.81K |
| -Change in receivables | -1,152.82%-11.76K | 195.91%25.45K | 35.84%15.85K | -2,390.20%-36.23K | -381.88%-57.61K | 105.30%1.12K | -57.57%8.6K | 174.20%11.67K | -96.78%1.58K | -139.80%-11.96K |
| -Change in inventory | 30.01%46.69K | 213.30%6.99K | -224.81%-60.24K | 182.77%109K | 284.28%30.99K | -26.77%35.91K | -114.64%-6.17K | 538.09%48.26K | 191.84%38.55K | -210.72%-16.82K |
| -Change in prepaid assets | -167.49%-2.72K | -79.27%1.89K | -225.51%-10.94K | 155.60%23.35K | 121.20%1.51K | 53.32%4.02K | -48.91%9.11K | 58.61%8.72K | 226.20%9.14K | 37.60%-7.11K |
| -Change in payables and accrued expense | -73.32%4.96K | 123.91%3.44K | -392.42%-14.96K | 109.43%5.03K | 82.11%-4.28K | 257.66%18.59K | -55.12%-14.4K | 124.39%5.12K | -8.04%-53.27K | -209.43%-23.93K |
| Dividends received (cash flow from operating activities) | ---- | ---- | ---- | 0.00%17.65K | ---- | ---- | ---- | ---- | 0.00%17.65K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 12.71%35.34K | 135.97%15.08K | -248.01%-67.08K | 99.79%-414 | 52.25%-35.17K | 122.95%31.35K | -1,330.65%-41.92K | 133.71%45.32K | 58.33%-201.74K | -169.48%-73.66K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 50K | -79.82%50K | 0.00%50K | 0 | 0 | 0 | -58.70%247.78K | -50.00%50K |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | ---2.22K | --0 |
| Net investment purchase and sale | --0 | --0 | --50K | -80.00%50K | 0.00%50K | --0 | --0 | --0 | -58.33%250K | -50.00%50K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --50K | -79.82%50K | 0.00%50K | --0 | --0 | --0 | -58.70%247.78K | -50.00%50K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 91.74%-4.17K | 0 | 0 | 0 | 63.44%-4.17K | 47.93%-50.5K | 78.76%-15.29K |
| Net issuance payments of debt | --0 | --0 | --0 | 91.74%-4.17K | --0 | --0 | --0 | 63.44%-4.17K | 47.93%-50.5K | 78.76%-15.29K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 91.74%-4.17K | --0 | --0 | --0 | 63.44%-4.17K | 47.93%-50.5K | 78.76%-15.29K |
| Net cash flow | ||||||||||
| Beginning cash position | 68.31%108.84K | -12.03%93.76K | 69.41%110.85K | -6.37%65.43K | -8.01%96.02K | 23.52%64.67K | 62.90%106.58K | -6.37%65.43K | 37.08%69.89K | 50.81%104.38K |
| Current changes in cash | 12.71%35.34K | 135.97%15.08K | -141.51%-17.08K | 1,119.46%45.42K | 138.07%14.83K | -39.74%31.35K | -5,393.58%-41.92K | 2,052.35%41.15K | -123.57%-4.46K | -5,861.39%-38.95K |
| End cash Position | 50.15%144.18K | 68.31%108.84K | -12.03%93.76K | 69.41%110.85K | 69.41%110.85K | -8.01%96.02K | 0.00%64.67K | 48.45%106.58K | -6.37%65.43K | -6.37%65.43K |
| Free cash from | 12.71%35.34K | 135.97%15.08K | -248.01%-67.08K | 99.80%-414 | 52.25%-35.17K | 122.95%31.35K | -1,330.65%-41.92K | 133.16%45.32K | 57.87%-203.96K | -169.48%-73.66K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.